Table of Content

1 INTRODUCTION 26
1.1 OBJECTIVES OF THE STUDY 26
1.2 MARKET DEFINITION 26
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 26
1.3 MARKET SCOPE 27
FIGURE 1 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SEGMENTATION 27
1.3.1 YEARS CONSIDERED FOR THE STUDY 27
1.4 CURRENCY 28
1.5 LIMITATIONS 28
1.6 STAKEHOLDERS 28
1.7 SUMMARY OF CHANGES 28
2 RESEARCH METHODOLOGY 30
2.1 RESEARCH DATA 30
FIGURE 2 RESEARCH DESIGN 30
2.1.1 SECONDARY DATA 31
2.1.1.1 Secondary sources 31
2.1.2 PRIMARY DATA 32
FIGURE 3 PRIMARY SOURCES 32
2.1.2.1 Key data from primary sources 33
2.1.2.2 Key industry insights 34
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 34
2.2 MARKET SIZE ESTIMATION 35
FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 35
2.2.1 GROWTH FORECAST 36
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 36
FIGURE 7 TOP-DOWN APPROACH 37
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 38
FIGURE 8 DATA TRIANGULATION METHODOLOGY 38
2.4 ASSUMPTIONS FOR THE STUDY 39
2.5 COVID-19 ECONOMIC ASSESSMENT 39
2.6 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 40
FIGURE 9 CRITERIA IMPACTING THE GLOBAL ECONOMY 40
FIGURE 10 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 41
3 EXECUTIVE SUMMARY 42
FIGURE 11 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 42
FIGURE 12 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE,
2021 VS. 2026 (USD MILLION) 43
FIGURE 13 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION) 43
FIGURE 14 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY REGION,
2021 VS. 2026 (USD MILLION) 44
4 PREMIUM INSIGHTS 45
4.1 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET OVERVIEW 45
FIGURE 15 INCREASING INCIDENCE OF CHRONIC DISORDERS TO DRIVE MARKET GROWTH 45
4.2 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE (2021–2026) 46
FIGURE 16 STENTS SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 46
4.3 NORTH AMERICA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET,
BY TYPE AND COUNTRY (2020) 47
FIGURE 17 THE US DOMINATED THE NORTH AMERICAN INTERVENTIONAL RADIOLOGY PRODUCTS MARKET IN 2020 47
4.4 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 48
FIGURE 18 INDIA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 48
5 MARKET OVERVIEW 49
5.1 INTRODUCTION 49
5.2 MARKET DYNAMICS 49
FIGURE 19 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 49
5.2.1 DRIVERS 49
5.2.1.1 Rising prevalence of chronic diseases 49
5.2.1.2 Growing geriatric population 50
5.2.1.3 Increasing demand for minimally invasive procedures 51
5.2.1.4 Favorable reimbursement scenario for interventional radiology procedures 51
TABLE 1 REIMBURSEMENT FOR INTERVENTIONAL RADIOLOGY PROCEDURES IN
THE US 51
5.2.2 RESTRAINTS 52
5.2.2.1 Availability of effective conventional first-level treatments 52
5.2.2.2 High cost and inaccessibility of advanced therapeutics 52
5.2.3 OPPORTUNITIES 52
5.2.3.1 Emerging markets 52
5.2.4 CHALLENGES 53
5.2.4.1 Entry barriers for new players 53
5.2.4.2 Product failures and recalls 53
5.3 REGULATORY LANDSCAPE 53
5.4 COVID-19 IMPACT ON THE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET 54
5.5 TECHNOLOGY ANALYSIS 55
5.6 PRICING ANALYSIS 55
TABLE 2 PRICES OF INTERVENTIONAL RADIOLOGY PRODUCTS 55
5.7 TRADE ANALYSIS 56
TABLE 3 IMPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SERVICES, BY COUNTRY,
2016-2020 (USD MILLION) 56
TABLE 4 EXPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SERVICES, BY COUNTRY,
2016-2020 (USD MILLION) 56
TABLE 5 IMPORT DATA FOR NEEDLES, CATHETERS, AND CANNULAE USED IN MEDICAL, SURGICAL, DENTAL, OR VETERINARY PROCEDURES, BY COUNTRY, 2016-2020 (USD MILLION) 57
TABLE 6 EXPORT DATA FOR NEEDLES, CATHETERS, AND CANNULAE USED IN MEDICAL, SURGICAL, DENTAL, OR VETERINARY PROCEDURES, BY COUNTRY, 2016-2020 (USD MILLION) 57
5.8 PATENT ANALYSIS 58
5.9 VALUE CHAIN ANALYSIS 58
FIGURE 20 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES 59
5.10 SUPPLY CHAIN ANALYSIS 59
FIGURE 21 DIRECT DISTRIBUTION: A STRATEGY PREFERRED BY PROMINENT COMPANIES 60
5.11 ECOSYSTEM ANALYSIS 61
5.11.1 ROLE IN THE ECOSYSTEM 62
TABLE 7 ROLE IN THE ECOSYSTEM 62
5.12 PORTER’S FIVE FORCES ANALYSIS 62
TABLE 8 PORTER’S FIVE FORCES 62
5.12.1 DEGREE OF COMPETITION 63
5.12.2 BARGAINING POWER OF SUPPLIERS 63
5.12.3 BARGAINING POWER OF BUYERS 63
5.12.4 THREAT OF SUBSTITUTES 63
5.12.5 THREAT OF NEW ENTRANTS 63
5.13 YCC SHIFT 64
6 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE 65
6.1 INTRODUCTION 66
TABLE 9 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 66
6.2 STENTS 66
6.2.1 INCREASING ADOPTION OF DRUG-ELUTING STENTS AND BIOABSORBABLE STENTS?A KEY FACTOR DRIVING MARKET GROWTH 66
TABLE 10 INTERVENTIONAL RADIOLOGY STENTS MARKET, BY REGION,
2019–2026 (USD MILLION) 67
6.3 CATHETERS 67
TABLE 11 INTERVENTIONAL RADIOLOGY CATHETERS MARKET, BY TYPE,
2019–2026 (USD MILLION) 67
TABLE 12 INTERVENTIONAL RADIOLOGY CATHETERS MARKET, BY REGION,
2019–2026 (USD MILLION) 68
6.3.1 DIAGNOSTIC CATHETERS 68
6.3.1.1 Diagnostic catheters held the largest share of the interventional radiology catheters market 68
TABLE 13 INTERVENTIONAL RADIOLOGY DIAGNOSTIC CATHETERS MARKET, BY REGION, 2019–2026 (USD MILLION) 68
6.3.2 THERAPEUTIC CATHETERS 69
6.3.2.1 Increasing adoption of minimally invasive therapeutic procedures to drive market growth 69
TABLE 14 INTERVENTIONAL RADIOLOGY THERAPEUTIC CATHETERS MARKET,
BY REGION, 2019–2026 (USD MILLION) 69
6.4 INFERIOR VENA CAVA FILTERS 69
6.4.1 INCREASING PREVALENCE OF PULMONARY EMBOLISM TO DRIVE MARKET GROWTH 69
TABLE 15 INTERVENTIONAL RADIOLOGY INFERIOR VENA CAVA FILTERS MARKET,
BY REGION, 2019–2026 (USD MILLION) 70
6.5 HEMODYNAMIC FLOW ALTERATION DEVICES 70
6.5.1 RISING NUMBER OF REGULATORY APPROVALS AND TECHNOLOGICAL ADVANCEMENTS TO FAVOR MARKET GROWTH 70
TABLE 16 INTERVENTIONAL RADIOLOGY HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION) 71
6.6 ANGIOPLASTY BALLOONS 71
6.6.1 RISING NUMBER OF REGULATORY APPROVALS FOR ANGIOPLASTY BALLOONS TO SUPPORT MARKET GROWTH 71
TABLE 17 INTERVENTIONAL RADIOLOGY ANGIOPLASTY BALLOONS MARKET,
BY REGION, 2019–2026 (USD MILLION) 72
6.7 THROMBECTOMY SYSTEMS 72
6.7.1 INCREASING NUMBER OF PRODUCT INNOVATIONS AND APPROVALS TO AID MARKET GROWTH 72
TABLE 18 INTERVENTIONAL RADIOLOGY THROMBECTOMY SYSTEMS MARKET,
BY REGION, 2019–2026 (USD MILLION) 72
6.8 EMBOLIZATION DEVICES 73
6.8.1 INCREASING INCIDENCE OF AORTIC ANEURYSMS IS A KEY FACTOR DRIVING MARKET GROWTH 73
TABLE 19 INTERVENTIONAL RADIOLOGY EMBOLIZATION DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION) 73
6.9 BIOPSY NEEDLES 73
6.9.1 RISING PREVALENCE OF CANCER TO DRIVE THE ADOPTION OF BIOPSY NEEDLE PROCEDURES 73
TABLE 20 INTERVENTIONAL RADIOLOGY BIOPSY NEEDLES MARKET, BY REGION,
2019–2026 (USD MILLION) 74
6.10 ACCESSORIES 74
TABLE 21 INTERVENTIONAL RADIOLOGY ACCESSORIES MARKET, BY TYPE,
2019–2026 (USD MILLION) 74
TABLE 22 INTERVENTIONAL RADIOLOGY ACCESSORIES MARKET, BY REGION,
2019–2026 (USD MILLION) 75
6.10.1 CONTRAST MEDIA 75
6.10.1.1 Contrast media segment held the largest share of the interventional radiology accessories market 75
TABLE 23 INTERVENTIONAL RADIOLOGY CONTRAST MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION) 75
6.10.2 GUIDEWIRES 76
6.10.2.1 Rising number of surgical procedures to favor market growth 76
TABLE 24 INTERVENTIONAL RADIOLOGY GUIDEWIRES MARKET, BY REGION,
2019–2026 (USD MILLION) 76
6.10.3 BALLOON INFLATION DEVICES 76
6.10.3.1 Growth in the number of angioplasty procedures to drive the demand for balloon inflation devices 76
TABLE 25 INTERVENTIONAL RADIOLOGY BALLOON INFLATION DEVICES MARKET,
BY REGION, 2019–2026 (USD MILLION) 77
6.10.4 OTHER ACCESSORIES 77
TABLE 26 INTERVENTIONAL RADIOLOGY MARKET FOR OTHER ACCESSORIES,
BY REGION, 2019–2026 (USD MILLION) 77
6.11 OTHER INTERVENTIONAL RADIOLOGY PRODUCTS 77
TABLE 27 OTHER INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY REGION, 2019–2026 (USD MILLION) 78
7 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE 79
7.1 INTRODUCTION 80
TABLE 28 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE,
2019–2026 (USD MILLION) 80
7.2 ANGIOGRAPHY 80
7.2.1 ANGIOGRAPHY IS THE LARGEST & FASTEST-GROWING SEGMENT OF
THE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET 80
TABLE 29 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR ANGIOGRAPHY,
BY REGION, 2019–2026 (USD MILLION) 81
7.3 ANGIOPLASTY 81
7.3.1 RISING PREVALENCE OF STROKE TO DRIVE MARKET GROWTH 81
TABLE 30 NUMBER OF TRANSLUMINAL CORONARY ANGIOPLASTY PROCEDURES PERFORMED, BY COUNTRY, 2015 VS. 2018 81
TABLE 31 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR ANGIOPLASTY,
BY REGION, 2019–2026 (USD MILLION) 82
7.4 BIOPSY & DRAINAGE 82
7.4.1 RISING PREVALENCE OF CANCER HAS INCREASED THE DEMAND FOR BIOPSY & DRAINAGE PROCEDURES 82
TABLE 32 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR BIOPSY & DRAINAGE, BY REGION, 2019–2026 (USD MILLION) 82
7.5 EMBOLIZATION 83
7.5.1 INCREASING DEMAND FOR EMBOLIZATION IN THE TREATMENT OF FIBROIDS TO DRIVE MARKET GROWTH 83
TABLE 33 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR EMBOLIZATION,
BY REGION, 2019–2026 (USD MILLION) 83
7.6 THROMBOLYSIS 83
7.6.1 RISING PREVALENCE OF DVT TO DRIVE MARKET GROWTH 83
TABLE 34 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR THROMBOLYSIS,
BY REGION, 2019–2026 (USD MILLION) 84
7.7 VERTEBROPLASTY 84
7.7.1 INCREASING CASES OF OSTEOPOROSIS TO DRIVE THE DEMAND FOR VERTEBROPLASTY PROCEDURES 84
TABLE 35 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR VERTEBROPLASTY,
BY REGION, 2019–2026 (USD MILLION) 84
7.8 NEPHROSTOMY 85
7.8.1 INCREASING PREVALENCE OF KIDNEY DISEASES TO SUPPORT MARKET GROWTH 85
TABLE 36 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR NEPHROSTOMY,
BY REGION, 2019–2026 (USD MILLION) 85
7.9 OTHER PROCEDURES 85
TABLE 37 NUMBER OF CHOLECYSTECTOMY PROCEDURES PERFORMED, BY COUNTRY, 2015 VS. 2018 86
TABLE 38 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR OTHER PROCEDURES, BY REGION, 2019–2026 (USD MILLION) 86
8 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION 87
8.1 INTRODUCTION 88
TABLE 39 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 88
8.2 CARDIOLOGY 88
8.2.1 CARDIOLOGY IS THE LARGEST APPLICATION SEGMENT OF THE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET 88
TABLE 40 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR CARDIOLOGY,
BY REGION, 2019–2026 (USD MILLION) 89
8.3 UROLOGY & NEPHROLOGY 89
8.3.1 INNOVATION AND DEVELOPMENT OF PRODUCTS LIKE DRAINAGE CATHETERS TO SUPPORT MARKET GROWTH 89
TABLE 41 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR UROLOGY & NEPHROLOGY, BY REGION, 2019–2026 (USD MILLION) 90
8.4 ONCOLOGY 90
8.4.1 ONCOLOGY IS THE FASTEST-GROWING APPLICATION SEGMENT IN
THE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET 90
TABLE 42 INCREASING INCIDENCE OF CANCER, BY REGION,
2020 VS. 2030 VS. 2040 (MILLION) 90
TABLE 43 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR ONCOLOGY,
BY REGION, 2019–2026 (USD MILLION) 91
8.5 GASTROENTEROLOGY 91
8.5.1 HIGH INCIDENCE OF GASTROINTESTINAL DISORDERS TO DRIVE MARKET GROWTH 91
TABLE 44 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR GASTROENTEROLOGY, BY REGION, 2019–2026 (USD MILLION) 92
8.6 NEUROLOGY 92
8.6.1 TECHNOLOGICAL ADVANCEMENTS TO SUPPORT MARKET GROWTH 92
TABLE 45 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR NEUROLOGY,
BY REGION, 2019–2026 (USD MILLION) 92
8.7 ORTHOPEDICS 93
8.7.1 RISING GERIATRIC POPULATION TO AID THE GROWTH OF THIS MARKET 93
TABLE 46 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR ORTHOPEDICS,
BY REGION, 2019–2026 (USD MILLION) 93
8.8 OTHER APPLICATIONS 93
TABLE 47 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2026 (USD MILLION) 93
9 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY REGION 94
9.1 INTRODUCTION 95
TABLE 48 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY REGION,
2019–2026 (USD MILLION) 95
9.2 NORTH AMERICA 96
FIGURE 22 NORTH AMERICA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SNAPSHOT 96
TABLE 49 NORTH AMERICA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 97
TABLE 50 NORTH AMERICA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 97
TABLE 51 NORTH AMERICA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET,
BY PROCEDURE, 2019–2026 (USD MILLION) 98
TABLE 52 NORTH AMERICA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 98
9.2.1 US 99
9.2.1.1 The US dominates the North American interventional radiology products market 99
TABLE 53 US: KEY MACROINDICATORS 99
TABLE 54 US: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 100
TABLE 55 US: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE, 2019–2026 (USD MILLION) 100
TABLE 56 US: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 101
9.2.2 CANADA 101
9.2.2.1 High burden of target diseases to drive the market in Canada 101
TABLE 57 CANADA: KEY MACROINDICATORS 101
TABLE 58 CANADA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 102
TABLE 59 CANADA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET,
BY PROCEDURE, 2019–2026 (USD MILLION) 102
TABLE 60 CANADA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 103
9.3 EUROPE 103
TABLE 61 NUMBER OF SURGICAL PROCEDURES PER 100,000 POPULATION,
BY COUNTRY, 2018 103
TABLE 62 EUROPE: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 104
TABLE 63 EUROPE: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 104
TABLE 64 EUROPE: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET,
BY PROCEDURE, 2019–2026 (USD MILLION) 105
TABLE 65 EUROPE: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 105
9.3.1 GERMANY 106
9.3.1.1 Germany held the largest share of the European market in 2020 106
TABLE 66 GERMANY: KEY MACROINDICATORS 106
TABLE 67 GERMANY: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 107
TABLE 68 GERMANY: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET,
BY PROCEDURE, 2019–2026 (USD MILLION) 107
TABLE 69 GERMANY: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 108
9.3.2 UK 108
9.3.2.1 Government insurance schemes to support market growth 108
TABLE 70 UK: KEY MACROINDICATORS 109
TABLE 71 UK: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 109
TABLE 72 UK: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE, 2019–2026 (USD MILLION) 110
TABLE 73 UK: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 110
9.3.3 FRANCE 111
9.3.3.1 Large number of interventional radiology procedures to propel market growth 111
TABLE 74 FRANCE: KEY MACROINDICATORS 111
TABLE 75 FRANCE: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 112
TABLE 76 FRANCE: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET,
BY PROCEDURE, 2019–2026 (USD MILLION) 112
TABLE 77 FRANCE: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 113
9.3.4 ITALY 113
9.3.4.1 Rising geriatric population in the country to support the market growth 113
TABLE 78 ITALY: KEY MACROINDICATORS 113
TABLE 79 ITALY: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 114
TABLE 80 ITALY: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE, 2019–2026 (USD MILLION) 114
TABLE 81 ITALY: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 115
9.3.5 REST OF EUROPE (ROE) 115
TABLE 82 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2018 (% OF GDP) 115
TABLE 83 ROE: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 116
TABLE 84 ROE: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE, 2019–2026 (USD MILLION) 116
TABLE 85 ROE: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 117
9.4 ASIA PACIFIC 117
FIGURE 23 ASIA PACIFIC: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SNAPSHOT 118
TABLE 86 ASIA PACIFIC: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 119
TABLE 87 ASIA PACIFIC: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET,
BY TYPE, 2019–2026 (USD MILLION) 119
TABLE 88 ASIA PACIFIC: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET,
BY PROCEDURE, 2019–2026 (USD MILLION) 120
TABLE 89 ASIA PACIFIC: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 120
9.4.1 JAPAN 121
9.4.1.1 Japan accounted for the largest share of the APAC market in 2020 121
TABLE 90 JAPAN: KEY INDICATORS 121
TABLE 91 JAPAN: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 122
TABLE 92 JAPAN: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE, 2019–2026 (USD MILLION) 122
TABLE 93 JAPAN: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 123
9.4.2 CHINA 123
9.4.2.1 High tobacco consumption to favor market growth 123
TABLE 94 CHINA: ESTIMATED ANNUAL DES VOLUME AND NUMBER OF CLASS III HOSPITALS, BY CITY (2019) 124
TABLE 95 CHINA: KEY INDICATORS 124
TABLE 96 CHINA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 125
TABLE 97 CHINA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE, 2019–2026 (USD MILLION) 125
TABLE 98 CHINA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 126
9.4.3 INDIA 126
9.4.3.1 Improving healthcare infrastructure and rising number of hospitals to support market growth in India 126
TABLE 99 INDIA: KEY INDICATORS 126
TABLE 100 INDIA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 127
TABLE 101 INDIA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE, 2019–2026 (USD MILLION) 127
TABLE 102 INDIA: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 128
9.4.4 REST OF ASIA PACIFIC (ROAPAC) 128
TABLE 103 ROAPAC: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 129
TABLE 104 ROAPAC: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE, 2019–2026 (USD MILLION) 129
TABLE 105 ROAPAC: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 130
9.5 REST OF THE WORLD (ROW) 130
TABLE 106 ROW: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 131
TABLE 107 ROW: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY PROCEDURE, 2019–2026 (USD MILLION) 131
TABLE 108 ROW: INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 132
10 COMPETITIVE LANDSCAPE 133
10.1 OVERVIEW 133
FIGURE 24 KEY DEVELOPMENTS IN THE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, JANUARY 2018–APRIL 2021 133
10.2 MARKET SHARE ANALYSIS 134
TABLE 109 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET: DEGREE OF COMPETITION (2020) 134
10.3 COMPANY EVALUATION QUADRANT 135
10.3.1 STARS 135
10.3.2 EMERGING LEADERS 135
10.3.3 PERVASIVE PLAYERS 135
10.3.4 PARTICIPANTS 135
FIGURE 25 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET: COMPANY EVALUATION QUADRANT, 2020 136
10.4 COMPANY EVALUATION QUADRANT FOR SME/START-UPS 137
10.4.1 PROGRESSIVE COMPANIES 137
10.4.2 STARTING BLOCKS 137
10.4.3 RESPONSIVE COMPANIES 137
10.4.4 DYNAMIC COMPANIES 137
FIGURE 26 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET: COMPANY EVALUATION QUADRANT FOR SME & START-UPS, 2020 138
10.5 COMPETITIVE SCENARIO 139
FIGURE 27 MARKET EVALUATION MATRIX, 2018–2021 139
10.5.1 DEALS 139
TABLE 110 DEALS 139
10.5.2 PRODUCT LAUNCHES 140
TABLE 111 PRODUCT LAUNCHES 140
10.5.3 OTHER DEVELOPMENTS 141
TABLE 112 OTHER DEVELOPMENTS 141
?
10.6 COMPANY PRODUCT FOOTPRINT 142
TABLE 113 COMPANY FOOTPRINT 142
FIGURE 28 COMPANY PRODUCT FOOTPRINT 144
FIGURE 29 COMPANY APPLICATION FOOTPRINT 145
TABLE 114 COMPANY GEOGRAPHICAL FOOTPRINT 146
11 COMPANY PROFILES 147
11.1 KEY PLAYERS 147
(Business Overview, Products/Services/Solutions Offered, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
11.1.1 MEDTRONIC PLC 147
TABLE 115 MEDTRONIC: BUSINESS OVERVIEW 147
FIGURE 30 MEDTRONIC: COMPANY SNAPSHOT (2020) 148
11.1.2 BOSTON SCIENTIFIC CORPORATION 152
TABLE 116 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 152
FIGURE 31 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2020) 153
11.1.3 BECTON, DICKINSON AND COMPANY 157
TABLE 117 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 157
FIGURE 32 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020) 158
11.1.4 ABBOTT 161
TABLE 118 ABBOTT: BUSINESS OVERVIEW 161
FIGURE 33 ABBOTT: COMPANY SNAPSHOT (2020) 162
11.1.5 CARDINAL HEALTH 165
TABLE 119 CARDINAL HEALTH: BUSINESS OVERVIEW 165
FIGURE 34 CARDINAL HEALTH: COMPANY SNAPSHOT (2020) 166
11.1.6 B. BRAUN MELSUNGEN AG 168
TABLE 120 B. BRAUN MELSUNGEN: BUSINESS OVERVIEW 168
FIGURE 35 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2020) 169
TABLE 121 EXCHANGE RATES USED FOR THE CONVERSION OF EUR TO USD 169
11.1.7 STRYKER 173
TABLE 122 STRYKER: BUSINESS OVERVIEW 173
FIGURE 36 STRYKER: COMPANY SNAPSHOT (2020) 173
11.1.8 TERUMO MEDICAL CORPORATION 176
TABLE 123 TERUMO MEDICAL CORPORATION: BUSINESS OVERVIEW 176
FIGURE 37 TERUMO MEDICAL CORPORATION: COMPANY SNAPSHOT (2019) 176
TABLE 124 EXCHANGE RATES USED FOR THE CONVERSION OF JPY TO USD 177
11.1.9 COOK MEDICAL 179
TABLE 125 COOK MEDICAL: BUSINESS OVERVIEW 179
11.1.10 BIOSENSORS INTERNATIONAL GROUP, LTD. 182
TABLE 126 BIOSENSORS INTERNATIONAL GROUP, LTD.: BUSINESS OVERVIEW 182
11.1.11 TELEFLEX INCORPORATED 184
TABLE 127 TELEFLEX INCORPORATED: BUSINESS OVERVIEW 184
FIGURE 38 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2020) 184
11.1.12 IVASCULAR S.L.U. 186
TABLE 128 IVASCULAR S.L.U.: BUSINESS OVERVIEW 186
11.1.13 PENUMBRA, INC. 188
TABLE 129 PENUMBRA, INC.: BUSINESS OVERVIEW 188
FIGURE 39 PENUMBRA, INC.: COMPANY SNAPSHOT (2020) 188
11.1.14 BIOTRONIK SE & CO. KG 191
TABLE 130 BIOTRONIK SE & CO. KG: BUSINESS OVERVIEW 191
11.1.15 ENDOCOR GMBH 194
TABLE 131 ENDOCOR GMBH: BUSINESS OVERVIEW 194
11.1.16 MERIL LIFE SCIENCES PVT. LTD. 196
TABLE 132 MERIL LIFE SCIENCES PVT. LTD.: BUSINESS OVERVIEW 196
11.2 OTHER PLAYERS 198
11.2.1 PALEX MEDICAL SA 198
11.2.2 URESIL, LLC 199
11.2.3 ALVIMEDICA 200
11.2.4 CARDIONOVUM GMBH 202
11.2.5 SMT 203
11.2.6 MEDINOL LTD. 205
11.2.7 COMED B.V. 206
11.2.8 SCITECH 207
11.2.9 BALTON SP. Z O.O. 208
11.2.10 RONTIS CORPORATION 209
*Business Overview, Products/Services/Solutions Offered, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
12 APPENDIX 211
12.1 INSIGHTS FROM INDUSTRY EXPERTS 211
12.2 DISCUSSION GUIDE 212
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 216
12.4 AVAILABLE CUSTOMIZATIONS 218
12.5 RELATED REPORTS 218
12.6 AUTHOR DETAILS 219